Bladder cancer treatment in India
Most bladder cancers are found early, confined to the lining, and treated by scraping them out through a telescope with no external incision at all. A minority have grown into the bladder wall and need much bigger treatment. Which of those you have changes everything, and it is decided by one biopsy.
- First symptom
- Blood in the urine, usually painless. It always needs investigating
- Two groups
- Non-muscle-invasive, treated through a telescope; muscle-invasive, needing major treatment
- Indicative cost
- Radical cystectomy with ileal conduit, robotic: $8,500โ9,000, 5 days
- Early disease
- TURBT plus BCG or chemotherapy into the bladder, and long-term surveillance
- The big decision
- Removing the bladder, or trying to preserve it with chemoradiation
- First step
- A uro-oncologist reviews your cystoscopy and biopsy reports on video, free
Blood in the urine is never normal
Painless blood in the urine, even once, even if it clears up, needs investigating. It is the commonest first sign of bladder cancer, and because it stops on its own people frequently wait months. A cystoscopy, a short look inside the bladder with a telescope, settles it. Bladder cancer caught early is very treatable; the same cancer found two years later often is not.
The distinction that decides your treatment
Bladder cancer is really two diseases wearing one name, and the dividing line is whether the tumour has grown into the muscle layer of the bladder wall.
Non-muscle-invasive (the majority)
- Confined to the bladder lining
- Removed through a telescope, no external incision
- Followed by BCG or chemotherapy instilled into the bladder
- The bladder is kept
- Recurs often, so surveillance cystoscopies continue for years
Muscle-invasive
- Grown into the bladder wall muscle
- Needs chemotherapy then removal of the bladder, or chemoradiation
- Major surgery with a permanent change to how you pass urine
- Curable, but the treatment is substantial
- Delay costs a great deal here
The pathologist's report from your TURBT is what tells you which group you are in. If you have that report, a specialist can give you a meaningful opinion from it. If you do not have it, get it before anything else.
TURBT and BCG
TURBT, transurethral resection of bladder tumour, removes the growth through a telescope passed up the urethra. It is both the treatment for early disease and the test that stages it. There is no external cut.
Because early bladder cancer recurs frequently, TURBT alone is often not enough. BCG, a weakened bacterium originally developed as a tuberculosis vaccine, is instilled into the bladder in a course of treatments and provokes an immune reaction against remaining cancer cells. It is one of the older and more effective immunotherapies in medicine. Chemotherapy instilled into the bladder is the alternative in some cases.
The part people underestimate is surveillance. After early bladder cancer you need repeat cystoscopies on a schedule for years, because recurrence is common and catching it early keeps it in the treatable group. Before travelling for treatment, establish who will do those cystoscopies where you live. A cure abroad followed by no surveillance at home is a poor bargain.
Removing the bladder
For muscle-invasive disease, the standard approach is chemotherapy first, then removal of the bladder, a radical cystectomy. In men the prostate is usually removed at the same time; in women the operation is more extensive. Lymph nodes are cleared. It is done robotically at an indicative $8,500 to $9,000 with a five-day hospital stay.
Urine then needs somewhere to go, and this is the part of the conversation that matters most to how you will live afterwards.
- Ileal conduit (urostomy). A short segment of intestine carries urine to an opening on the abdomen, draining into a bag worn on the skin. Simpler, more reliable, fewer complications, and it is what the partner price covers. Most people adapt well; the adjustment is real and worth preparing for.
- Neobladder. A new bladder is constructed from intestine and joined to the urethra, so you pass urine more or less normally. Attractive in principle, and it needs suitable anatomy, a longer operation, and a patient willing to learn a new way of emptying. Continence at night is often imperfect. Not everyone is a candidate.
Ask which is being proposed and why, and ask to speak to the stoma nurse before surgery rather than after. Practical preparation makes an enormous difference to how the first months feel. If you will be returning to a country where stoma supplies are hard to obtain, say so before the decision is made, because it is a legitimate factor.
Keeping the bladder
For some patients with muscle-invasive disease, a bladder-preserving approach combines maximal TURBT, chemotherapy and radiotherapy. It suits carefully selected tumours, and it requires committed follow-up because the bladder that is kept must then be watched closely.
It is a reasonable option to ask about, particularly if the prospect of losing the bladder is what is stopping you from starting treatment. What it is not is an easier route: the follow-up burden is higher, and if the cancer returns, surgery afterwards is more difficult.
If it has spread
Bladder cancer that has spread beyond the bladder is treated with drug therapy rather than surgery. Immunotherapy has changed outcomes here meaningfully for some patients, and chemotherapy remains central. Whether immunotherapy is likely to help you depends on testing, so ask what testing has been done on your tumour before accepting either a recommendation or a refusal.
| Procedure | Indicative cost | Hospital stay |
|---|---|---|
| Radical cystectomy with ileal conduit, robotic | $8,500โ9,000 | 5 days |
| Chemotherapy, per cycle | $800 | Day care |
| Chemoradiation (combined course) | $6,500 | 6 weeks |
Questions patients ask
Can bladder cancer be cured with surgery?
Often, yes. Early bladder cancer confined to the lining is removed through a telescope and the bladder is kept, though it recurs frequently so surveillance continues for years. Muscle-invasive cancer is usually curable with chemotherapy followed by removal of the bladder, or in selected cases with chemoradiation that preserves it.
How much does bladder cancer surgery cost in India?
The indicative partner-hospital price for a robotic radical cystectomy with ileal conduit is $8,500 to $9,000 with a five-day stay. Chemotherapy is $800 per cycle and a combined chemoradiation course is $6,500. TURBT and BCG are not listed separately and will be in your written estimate.
Will I need a bag after bladder removal?
With an ileal conduit, yes: urine drains through a short segment of intestine to an opening on the abdomen into a bag. A neobladder built from intestine avoids the bag and lets you pass urine more normally, but it needs suitable anatomy, a longer operation, and accepting that night-time continence is often imperfect. Ask which is proposed and why, and speak to a stoma nurse before surgery.
What is BCG treatment for bladder cancer?
BCG is a weakened bacterium, originally a tuberculosis vaccine, instilled into the bladder in a course of treatments. It provokes an immune reaction against remaining cancer cells and is one of the older and more effective immunotherapies in medicine. It is used after TURBT for early disease to reduce recurrence.
Is there any way to avoid losing my bladder?
For selected muscle-invasive tumours, a bladder-preserving approach combines maximal TURBT, chemotherapy and radiotherapy. It is a legitimate option to ask about. It is not an easier route: follow-up is more demanding, and surgery afterwards is harder if the cancer returns.
I passed blood in my urine once and it stopped. Does it matter?
Yes. Painless blood in the urine that clears on its own is the classic first sign of bladder cancer, and because it stops, people often wait months. A cystoscopy settles it quickly. Bladder cancer found early is very treatable; the same cancer two years later frequently is not.
What is the latest treatment for bladder cancer?
For advanced disease, immunotherapy has meaningfully changed outcomes for some patients, and whether it is likely to help you depends on testing of your tumour. Ask what testing has been done before accepting either a recommendation or a refusal. For early disease, the established combination of TURBT and BCG remains hard to beat.